MetaCap

Larimar Therapeutics (LRMR) News

NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.14-0.08 (-2.48%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LRMR news summary

We found 5 recent headlines mentioning Larimar Therapeutics (LRMR): 2 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, LRMR is down 2.48% at $3.14. The most recent story, "Larimar Therapeutics Completes BLA Submission for Nomlabofusp and Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Larimar Therapeutics headlines

Stocks mentioned alongside LRMR

Compare LRMR